Therachon
Latest round
- Series A
Last raised
- Jan 2017
Total raised
- $43M
Investors
- 5
About Therachon
Founded in 2014 in Basel, Switzerland, Therachon AG specializes in biopharmaceuticals targeting rare diseases. The company was acquired by Pfizer Inc.00 mn.Therachon AG's product offerings focus on biopharmaceuticals designed to treat rare diseases.Therachon AG generates revenue through partnerships with healthcare systems and direct sales of its therapies.In the years following its acquisition, Therachon AG intends to leverage Pfizer's extensive resources to expedite the development of upcoming therapies and expand its market presence.
Who invested in Therachon
5 investors across 3 rounds
See all investors in Therachon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Therachon
Who invested in Therachon?
Therachon has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Therachon raised?
Therachon has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Therachon last raise money?
Therachon's most recent round on record is a Series A, in Jan 2017.
What does Therachon do?
Founded in 2014 in Basel, Switzerland, Therachon AG specializes in biopharmaceuticals targeting rare diseases.
Where is Therachon headquartered?
Therachon is headquartered in Basel, Switzerland.
Which VCs invest in companies like Therachon?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Therachon's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Therachon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.